The respiratory tract is an attractive target organ for novel diagnostic and therapeutic applications with nano-sized carriers, but their immune effects and interactions with key resident antigenpresenting cells (APCs) such as dendritic cells (DCs) and alveolar macrophages (AMs) in different anatomical compartments remain poorly understood. Polystyrene particles ranging from 20 nm to 1,000 nm were instilled intranasally in BALB/c mice, and their interactions with APC populations in airways, lung parenchyma, and lung-draining lymph nodes (LDLNs) were examined after 2 and 24 hours by flow cytometry and confocal microscopy. In the main conducting airways and lung parenchyma, DC subpopulations preferentially captured 20-nm particles, compared with 1,000-nm particles that were transported to the LDLNs by migratory CD11b low DCs and that were observed in close proximity to CD3 1 T cells. Generally, the uptake of particles increased the expression of CD40 and CD86 in all DC populations, independent of particle size, whereas 20-nm particles induced enhanced antigen presentation to CD4
In the area of innovative biomedical applications, the potential benefits of manufactured nanoparticles have been increasingly recognized. In particular, nano-sized carriers have been proposed as promising novel diagnostic, therapeutic, and vaccination approaches to a variety of human diseases (1) (2) (3) (4) . The sitespecific delivery of diagnostic molecules, drugs, vaccines, peptides, and genes through nano-sized carrier systems offers potential advantages, including fewer systemic side effects (5) . Another potential advantage of particulate delivery systems involves their "natural" targeting to antigen-presenting cells (APCs). The delivery of nano-sized carriers to the lung has been receiving increasing interest because of the large surface area provided by the gas-exchange region, limited local proteolytic activity (6) , noninvasiveness, and fine anatomical barriers for systemic access (7, 8) . Shape, surface-charge modifications, and particle sizes are key determinants governing the fate of particles within the respiratory tract. Inhaled particles deposit in a sizedependent manner in the respiratory tract (9-11). Smaller particle sizes reach alveolar spaces of the lung parenchyma (LP) (12, 13) , and their clearance from the respiratory tract is delayed (14) because of the absence of an efficient clearing mechanism such as the mucociliary escalator in gas-exchange regions. Moreover, alveolar macrophages, primarily responsible for particle clearance in the gas-exchange regions, clear nanoparticles less efficiently compared with larger particles (13) . Smaller particle size and prolonged persistence in the alveolar space may also favor rapid particle translocation across the air-blood barrier into both the systemic and lymphatic circulations, with subsequent dissemination to extrapulmonary organs (15, 16) . Furthermore, the large surface area-to-mass ratio of nanoparticles provides increased surfaces that interact with the biological microenvironment. Although this increased surface potentially improves efficiency as a carrier for therapeutic or diagnostic molecules (8, 17) , it may also trigger severe inflammatory responses (13) . Regarding the initiation and maintenance of inflammatory responses, insufficient data are available to date on the interactions of nanoparticles with the pulmonary immune system (8) . Pulmonary APCs are considered sentinels of the immune system because of their strategic localization, their phagocytic activity, and their ability to present antigen (18) (19) (20) (21) . Two major populations of so-called "conventional" or myeloid-origin dendritic cells have been extensively characterized in the conducting airways and the LP of mice, namely, CD11c
1 major histocompatibility complex (MHC) Class (20, 22, 23) . CD11b high DC subsets have been shown to activate both CD8 and CD4 responses (24) . Furthermore, CD11b low DCs have been shown to play an important role in viral responses (25) and apoptotic cell uptake (26) . Clarifying which APC/DC populations primarily interact with particles and traffic these from different respiratory tract compartments to lungdraining lymph nodes (LDLNs) is paramount to understanding related downstream inflammatory and immune responses.
Despite a considerable body of publications addressing the importance of particle size for the deposition, translocation, and interaction with cells (16, (26) (27) (28) (29) , a disconcerting paucity of data describes how size determines interactions with resident APC populations within different anatomical compartments in the respiratory tract. In this study, we hypothesized that particle size determines which resident APC population is primarily targeted in a particular respiratory tract compartment. We evaluated distribution of carboxylated, yellow-green-labeled polystyrene (PS) particles of different sizes in different respiratory tract compartments, uptake by resident APC populations, and trafficking to the LDLNs after an intranasal instillation in naive BALB/c mice. The data presented here clearly showed a sizedependent uptake of PS particles by different respiratory tract APC subpopulations, with an enhanced uptake of smaller PS particles by lung DCs. Finally, we demonstrate that small but not large particles in the nanometer range, but not large ones in the micrometer range, are able to induce enhanced CD4
1 T-cell proliferation in the LDLNs.
MATERIALS AND METHODS

Mice
Female BALB/c and BALB/c DO11.10 T cell receptor (TCR) transgenic mice were bred specific pathogen free at the Department of Clinical Research, University of Bern (Bern, Switzerland) and used at 8 to 12 weeks of age, in compliance with the standards of the European Convention of Animal Care, under permission number 64/07 from the Animal Experimentation Committee at the University of Bern.
PS Particles and Characterization
Yellow-green-labeled, carboxylate-modified 20-nm PS beads were purchased from Life Technologies (Grand Island, NY), and 50-nm, 100-nm, 200-nm, and 1,000-nm PS beads were purchased from Polysciences (Warrington, PA). All particles were endotoxin-free (according to the Limulus Amebocyte Lysate Test; Lonza, Walkersville, MD). Transmission electron microscopy was performed, using a Morgagni microscope (at 80 kV; FEI, Hillsboro, OR), and the zeta potential was determined with a Brookhaven-90 Plus Particle Size Analyzer (Brookhaven Instruments Corporation, Holtsville, NY) ( Figure 1 ). Particles were instilled under light inhalation anesthesia with 3% isoflurane (Provet, Lyssach, Switzerland). Particle stock solutions were diluted to 0.1% (wt/vol) in PBS, and 50 ml (50 mg) of particles or of PBS (control) were delivered intranasally.
Cell Preparations, Conducting Airways, Lung Parenchyma, and Lung-Draining Lymph Nodes Cells were prepared from collagenase digests of trachea, lung parenchyma, and lymph nodes as previously described (20, 30, 31) . Briefly, animals were killed with 500 mg/kg of intraperitoneal phenobarbitone sodium (Esconarkon, Streuli, Switzerland). After lavage, the LP, tracheas, and main bronchi were excised. Pooled LDLNs (parathymic and posterior mediastinal) and nondraining inguinal lymph nodes (ILNs) were collected, and single-cell suspensions were prepared.
Flow Cytometry
Unless indicated otherwise, all antibodies were bought from eBioscience (Vienna, Austria). Cells were incubated on ice with Fc (the Fragment, crystallizable region) block (anti-mouse CD16/CD32) for 10 minutes, followed by anti-mouse monoclonal antibodies, namely, Pacific Blue-conjugated anti-F4/80, anti-CD8a, anti-CD3 (Life Technologies), phycoerythrin (PE)-conjugated anti-I-A/I-E (MHC Class II), anti-DO11.10 TCR (KJ-126), biotin-conjugated anti-CD40, anti-CD86, anti-CD103, and anti-CD3 (secondary, streptavidin-PE-Cy5), APCconjugated anti-CD11c and anti-CD4, and APC-Cy7-conjugated antiCD11b. Cells were analyzed by flow cytometry, using an LSRII flow cytometer (BD Biosciences, Franklin Lakes, NJ).
Immunofluorescence and Laser Scanning Microscopy
Tissue was embedded in Tissue-Tek O.C.T. compound (Sakura, Alphen aan den Rijn, Netherlands) and snap-frozen. Cryosections of 7 mm were cut (30505 Cryostat; Leica Microsystems, Heerbrugg, Switzerland), rinsed in staining buffer (PBS, 0.1% BSA, and 0.01% NaN 3 ), and permeabilized in 0.2% Triton X-100 (Sigma-Aldrich, Buchs, Switzerland). Sections were stained with phalloidin-rhodamine (F-actin; Life Technologies, Zug, Switzerland), Alexa 647-conjugated anti-I-A/I-E (MHC Class II; BioLegend, Luzern, Switzerland), biotin-conjugated anti-F4/80, and anti-CD3e, followed by streptavidin-eFluor 450. Mounted optical sections were analyzed as previously described (32) .
Adoptive Transfer of CFSE-Labeled, Ovalbumin-Specific T Cells
Adoptive transfer was performed as previously described (30, 31) . Briefly, DO11.10 lymph node cells were resuspended to 2.5 3 10 7 /ml in prewarmed buffer and labeled with carboxyfluorescein diacetate, succinimidyl ester (CFSE). Washed cells were injected intravenously at 5-10 3 10 6 cells/recipient in 200 ml of PBS. Two days later, particles were instilled intranasally as already described, followed by 50 mg ovalbumin (OVA; Sigma-Aldrich) in 50 ml intranasal PBS. Seventy-two hours later, ILN and LDLN cells were labeled for CD4 and KJ-126, and CFSE profiles were assessed by flow cytometry (33) . Data are expressed as an "expansion index" (EI) (34) , derived using the proliferation module of FlowJo analysis software (Tree Star, Ashland, OR).
Statistical Analyses
Unless indicated otherwise, data represent the means 6 SEMs of three to eight different experiments. Unpaired Student t tests were used to calculate significance (GraphPad Prism, La Jolla, CA), with P , 0.05 considered statistically significant.
RESULTS
Characterization of Commercial PS Particles
Before in vivo utilization, we thoroughly characterized the different sizes of PS particles, assessing for size distribution and zeta potential, as shown in Figure 1 and Table 1 . All particles were negatively charged with a zeta potential between 27 and 217 mV, with an exception measured in 200-nm particles showing a particularly lower zeta potential of 241.5 mV ( Table 1) . The systematic endotoxin testing of particles ruled out any contamination with LPS (data not shown).
Particle Distribution within Different Anatomical Compartments of the Respiratory Tract
To visualize particle-cell interactions in different compartments of the respiratory tract, trachea, LP, and LDLNs were collected after the instillation of particles and analyzed with laser scanning microscopy (LSM). A qualitative assessment by LSM identified no obvious differences in the distribution of particles at any size between 2 hours and 24 hours after exposure, except for LDLNs, in which particles were only detected 24 hours after exposure (data not shown). Therefore, the distribution of different sizes of PS particles in trachea, LP, and LDLNs was visualized by LSM only after 24 hours (Figure 2 and Figure E1 in the online supplement). Within the trachea, particles of all sizes were primarily located on the luminal side of the epithelium. An exception were 20-nm particles, also detected in the lamina propria, and frequently associated with subepithelial MHC Class II 1 DCs (Figure 2 ). In the LP, all particle size classes were evenly distributed throughout the tissue, and the majority was taken up by alveolar macrophages (AMs; MHC Class II 1 F4/80 1 ), with a small number seen within MHC Class II 1 DCs (Figure 2 ). In the LDLNs, only 50-nm and 20-nm particles were detected in high quantities, often within MHC Class II 1 DCs that interacted with CD3
1 T cells in the T-cell areas of LDLNs ( Figure  2 ). We performed a comparative analysis of total particle distribution within AMs and CD11b high and CD11b low DC populations, 2 hours and 24 hours after particle exposure by flow cytometry ( Figures 3A and 3B ). Flow cytometry essentially supported the imaging data from microscopy by confirming that the majority of particles were associated with AMs, independent of particle size ( Figure 3B ). However, size-dependent distribution occurred in the trachea, where an elevated frequency (z 45% in total) of CD11b high and CD11b low DCs contained 20-nm particles, compared with the frequency of particle-positive AMs found in this compartment. In the lung parenchyma, approximately 30% of total cells bearing 20-nm particles after 2 hours were CD11b high DCs and CD11b low DCs, whereas DCs containing larger particles comprised less than 10% of the total particle-carrying cell population. Twenty-four hours after particle exposure, higher frequencies of CD11b high DCs and CD11b low DCs contained 20-nm and 50-nm particles (40% and 25%, respectively), compared with DCs associated with 100-nm, 200-nm, and 1,000-nm particles ( Figure  3B ). Comparing both DC populations analyzed, at the early time point (2 h), relatively more CD11b low DCs had taken up particles, contrasting with the higher frequencies of CD11b high DCs at the later (24 h) time point, which were associated with particles, particularly in the bronchoalveolar lavage fluid (BALF) and LP ( Figure 3B ).
Flow Cytometry Analysis of Particle Uptake and Trafficking by Lung APCs in Different Respiratory Tract Compartments
To analyze size-dependent particle uptake in different anatomical compartments, and trafficking from the respiratory tract to the LDLNs, we performed tissue sampling using a 2-hour time point to study early events related to particle-cell interactions, and a 24-hour time point to investigate later events related to particle trafficking, particularly in LDLNs.
For the analysis of size dependence, the particle uptake of submicron particles was compared with that of 1,000-nm particles. Respiratory tract APC populations (i.e., AMs, CD11b
high DCs, and CD11b low DCs) were characterized by flow cytometry after particle exposure. In LDLNs, two different subpopulations of migratory CD8a low DCs and resident CD8a high DCs were identified and characterized, as previously described (31) . Based on their expression of CD11b, these two subpopulations were further subdivided into four subsets. Figure 4 illustrates the gating strategy used to analyze APC subpopulations in different respiratory tract compartments.
Results of the particle uptake study are summarized in Figure  5 . Within the trachea at the 2-hour time point, particle uptake by DCs was low for each size class ( Figure 5 ). After 24 hours, a significantly higher uptake was only seen for 20-nm particles in CD11b low DCs, compared with the uptake of 1,000-nm particles, ( Figure 5 ). Moreover, as early as 2 hours after exposure, intra-alveolar CD11b low LP DCs took up significantly more 20-nm, 100-nm, and 200-nm particles than larger 1,000-nm particles ( Figure 5 ). In comparison, intra-alveolar CD11b high LP DC subpopulations displayed no size-dependent particle uptake 2 hours after exposure. But after 24 hours, a significantly higher uptake of 20-nm and 50-nm particles occurred both in CD11b low DC and in CD11b high DCs, compared with 1,000-nm particle uptake ( Figure  5 ). In the LP, CD11b low DC and CD11b high DC subsets took up significantly more 20-nm particles after 2 hours and 24 hours, compared with 1,000-nm particles ( Figure 5 ). After 2 hours, uptake in the CD11b low DC subset of 50-nm particles was significantly higher than for 1,000-nm particles. At 24 hours, the preferential uptake of 50-nm particles occurred in both DC subpopulations, compared with 1,000-nm particles ( Figure 5 ).
To monitor size-dependent trafficking patterns of particles from the respiratory tract to LDLNs, single-cell suspensions from LDLNs were prepared 24 hours after particle exposure. Particle uptake and costimulatory molecule expression were determined in migratory DCs and resident DC subpopulations, as well as in their CD11b high and CD11b low subsets ( Figure 5 ). On a constant basis, the vast majority of particles in the LDLNs were associated with migratory CD8a low DCs, whereas resident CD8a high DCs (in the majority in the CD11b high subset) were less frequently positive for particles, independent of size (Figure Although airway macrophages generally did not display sizedependent particle uptake at either 2-hour or 24-hour time points after exposure (except for the increased uptake of 20-nm particles after 2 hours, compared with 1,000-nm particles), their alveolar macrophage counterparts more frequently took up smaller particle sizes 24 hours after exposure, compared with the 1,000-nm particles ( Figure 5 ). Alveolar macrophages from LP cell suspensions displayed similar particle uptake, albeit at the earlier 2-hour time point and at lower frequencies compared with 1,000-nm particles ( Figure 5 ). Frequencies at the later 24-hour time point were generally similar, with the exception of 50-nm particles, which produced results not significantly different from those for 1,000-nm particles.
Activation of Lung APCs in Different Respiratory Tract Compartments after the Administration of Different Particle Sizes
To monitor DC activation during particle exposure, the expression of costimulatory markers CD40 ( Figure 6 ) and CD86 (Figure E2 ) was analyzed in APC populations within different respiratory tract compartments, 2 hours (data not shown) and 24 hours after particle exposure. We observed a general tendency of all particle sizes to enhance the expression of costimulatory markers when taken up by pulmonary APCs. In the trachea, the percentages of CD11b high DCs and CD11b low DCs expressing CD40 ( Figure 6 ) and CD86 ( Figure E2 ) were significantly increased in most of the cells that had taken up particles, compared with nonexposed control cells. Similar results were obtained in DCs from BALF, particularly in the CD11b low subset ( Figure 6 and Figure E2 ). CD40 molecules were not up-regulated in alveolar CD11b low DCs exposed to 20-nm particles and in CD11b high DCs exposed to both 20-nm and 50-nm particles, compared with control cells (Figure 6 and Figure E2 ). Moreover, no significant difference in CD86 expression occurred in particle-exposed CD11b high alveolar DCs and control cells, with CD86 in this DC subpopulation constitutively expressed in nearly 100% of cells ( Figure E2 ). In the LP, similar to findings in BALF, CD11b high and CD11b low DCs exposed to the two smallest particle sizes did not express significantly enhanced CD40 when compared with control cells, unlike cells exposed to larger particles ( Figure 6 ). All particle sizes caused increased frequencies of CD86 expression in CD11b low DCs, but this was seen only for the largest 200-nm and 1,000-nm particles in CD11b high DCs ( Figure E2 ). In the LDLN migratory CD11b low DC subset, only 20-nm particles caused increased frequencies of CD40 expression, whereas larger 100-nm and 1,000-nm particles up-regulated CD40 expression in its counterpart, namely, the CD11b high migratory DC subset ( Figure 6 ). In both resident DC subsets, 20-nm Figure 2 . Distribution of fluorescent PS particles in different respiratory-tract compartments was visualized by laser scanning microscopy (LSM). Trachea, lung parenchyma (LP), and lung-draining lymph nodes (LDLNs) were collected 24 hours after intranasal administration of particles and processed for LSM. In each group, left images depict lowpower micrographs, and right images depict high-power micrographs. In the trachea, particles (yellow; arrowheads) were mainly located on the luminal side of the epithelium. Smaller 20-nm particles were also found within dendritic cells (DCs; red; asterisk) localized in or below the epithelium. In the LP, all particle sizes were evenly distributed. The vast majority were taken up by alveolar macrophages (turquoise/red; arrowheads), with a small number taken up by DCs (red). Within LDLNs, only 50-nm and 20-nm particles were found in larger quantities, and were associated with DCs (red; arrowheads) that closely interacted with T cells (turquoise; asterisks) in T-cell areas, whereas single larger particles were also localized inside DCs within the same areas. Markers represent actin (blue), I-A/I-E (red), F4/80 (turquoise; LP), CD3e (turquoise; LDLNs), and particles (yellow). Low-power micrographs show actin, I-A/I-E, and particles only. Representative photomicrographs from at least three independent experiments are shown. Please refer to Figure E1 in the online supplement for high-resolution images.
particles did not increase CD40 expression, in contrast to most of the larger particles. After exposure to most particles, the migratory CD11b low DC subset increased CD86 expression, contrasting with the migratory CD11b high DC subset that did not respond to particle exposure with increased CD86 expression ( Figure E2 ). In contrast, the resident CD11b low DC subset showed enhanced CD86 expression only when exposed to 100-nm and 200-nm particles, whereas the resident CD11b high DC subset up-regulated CD86 after exposure to particles of any size ( Figure E2 ).
In response to particle exposure, macrophages also up-regulated CD40 and CD86 expression, as shown in Figures 6 and E2 and as described in the online supplement.
Modulation of T-Cell Activation by Nanoparticles
The question arose whether size-dependent particle uptake and trafficking to LDLNs along with the up-regulation of costimulatory markers on DCs in LDLN may affect antigen-specific CD4 1 T-cell responses in LDLNs. To examine this, OVA-specific DO11.10 TCR transgenic CD4
1 T cells were labeled with CFSE and injected intravenously into recipient mice before sequential particle and OVA exposure. LDLNs and ILNs were then harvested, and transgenic CD4
1 KJ-126 1 T cells were identified and gated by flow cytometry ( Figure 7A ). The OVA-specific proliferation of CD4
1 T cells was analyzed by assessing the CFSE division profiles in lymph nodes 72 hours after OVA and particle exposure ( Figures 7B and 7C) . The expansion index (EI) was compared between draining LDLNs and nondraining ILN controls of mice that received OVA alone or OVA together with either 20-nm or 1,000-nm particles. Whereas the EI remained low (around 1) in non-lung-draining ILNs, the EI was significantly elevated in LDLNs that drained the respiratory tract. Although a trend for enhanced proliferation in mice receiving 20-nm particles was evident, no significant difference in EI was observed between animals exposed to 20-nm and 1,000-nm particles ( Figure 7C ). However, mice exposed to 20-nm particles showed significantly enhanced EI values, compared with animals that received OVA only ( Figure 7C ). ) that belong to other cell populations previously characterized (20) , not included in the current analysis for reasons of clarity. (B) Frequencies of total particle uptake events detected in the trachea, bronchoalveolar lavage fluid (BALF), and lung parenchyma were analyzed in AMs and in CD11b high and CD11b low DC populations, 2 hours and 24 hours after instillation. Bars show the means from at least six individual mice for each treatment across four independent experiments.
DISCUSSION
The development of nanomaterials for novel therapeutic and diagnostic clinical applications is on the rise, and the pulmonary route of administration is attractive for novel compounds. To date, a disconcerting lack of data has been available on how pulmonary immune responses are modified by particulates, particularly in relation to particle size and surface charge. In our study, aiming to analyze the size-dependent immunomodulatory effects of nanoparticles, the majority of particles were taken up independently of size by alveolar macrophages. In contrast, DCs displayed a selective uptake of 20-nm particles in the trachea and of both 20-nm and 50-nm particles in the lung parenchyma, compared to uptake of 1,000-nm particles. Furthermore, compared to 1,000-nm particles, smaller 20-nm and 50-nm particles were more frequently associated with migratory CD11b low DCs in LDLNs. In the lymph nodes, 20-nm but not 1,000-nm particles induced stronger antigen-specific CD4 1 T-cell proliferation, compared with antigen administered alone. A summary of the major findings in this study is shown in Table 2 .
We adopted a widely used model involving intranasal instillation to allow for the straightforward administration of particles to the airways and LP (20, 30, 31, 35, 36) , and we showed a homogenous distribution of particles in the lung by flow cytometry and confocal microscopy. Nevertheless, to interpret the data in the context of the particle application method used in this study remains essential (please refer to the online data supplement).
At the early time point investigated (i.e., after 2 hours), neither FACS analysis nor microscopy showed a significant uptake of particles in the airways or trafficking to LDLNs. In contrast, 24 hours after particle exposure, 12% of CD11b low and 7% of CD11b high airway mucosal DCs had captured smaller 20-nm particles, whereas only a low frequency of CD11b low and CD11b high DCs (1% and 2%, respectively) had taken up larger 1,000-nm particles. Confocal microscopy experiments provided a morphological confirmation of FACS findings, with 20-nm particles primarily localized in intraepithelial or subepithelial DC populations, whereas larger particles were rarely visualized in airway APC populations. In general, the mucociliary escalator leads to a rapid clearance of particles deposited in airways (37), preventing the uptake of high quantities of particles by local DCs. In addition, a recent intravital microscopy study demonstrated that alveolar DCs, but not airway DCs, captured 1,000-nm PS beads within 1 hour of administration (38) . Our work showed that 24 hours after administration, particle-bearing, mostly CD11b high DCs had migrated into the tracheal lumen. Lung parenchymal CD11b low and CD11b high DCs captured 20-nm particles 2 hours after exposure, whereas larger particles were taken up at lower frequencies. At the later 24-hour time point, both CD11b low and CD11b high DC subpopulations containing 20-nm particles were present in the conducting airways. Although DCs containing larger particles were also observed in airways, this occurred less frequently. Our findings are therefore partly in accordance with the study by Thornton and colleagues (38) , but we detected higher frequencies of LPDCs trafficking smaller 20-nm and 50-nm particles, and only very low frequencies of DCs bearing 1,000-nm particles. Although we monitored low subsets were further divided into particle-positive (open histograms) and particle-negative (solid histograms) cells, and compared with the identical subsets from nonexposed mice. The expression of costimulatory molecules (open histograms; solid histograms correspond to isotype controls) was determined in particle-positive and particle-negative cell populations. For simplification, the expression of costimulatory markers is only shown in particle-positive cells.
DC numbers only in LP and trachea (i.e., not in smaller airways), we did not detect differences in APC population frequencies 24 hours after particle exposure (data not shown). Finally, although the trafficking of particle-bearing DCs from the LP to conducting airways may account for particles seen in the conducting airways (38), we and others have shown that DCs may efficiently extend transepithelial dendrites into the airway lumen for direct antigen and possibly particle sampling (35, 36, 39, 40) .
Constituting the most frequent APC population in the LP, AMs outnumber DCs by approximately 5:1 (20) . Moreover, AMs captured particles irrespective of size, and are generally regarded as unable to migrate to LDLNs (20, 28, 41) . Although the uptake frequencies of 1,000-nm particles by AMs remained constant through the 2-hour and 24-hour time points, the uptake of smaller particles significantly increased at 24 hours (1,000 nm, 54%; 200 nm, 64%; 100 nm, 69%; 50 nm, 81%; and 20 nm, 91%). Although Oberdorster previously suggested that nano-sized particles were able to "evade" alveolar clearance by AMs and therefore more readily translocate into the lung interstitium, we observed that AMs more effectively captured particles in the nanometer than in the micrometer range (13) . These findings are in line with a recent study that evaluated the in vivo uptake of gold nanoparticles (16 nm) and showed that 94% of rat AMs took up particles after 24 hours (42) . In the present study, we performed a side-by-side analysis of AMs obtained from BALF and LP tissue digests. AMs from LP digests displayed reduced uptake frequencies, compared with their counterparts from BALF (50% reduction in the uptake of 20-nm particles, 2 h and 24 h after exposure), and did not increase the uptake of particles at less than 1,000 nm after 24 hours. Because we consider the AMs from LP digests and from BALF as identical populations, these differences were most likely attributable to the effects of the enzymatic digestion step, which may have caused the partial exocytosis of internalized particles.
The capture of 20-nm and 50-nm particles by airway mucosal and LPDCs was mirrored in LDLNs, where CD11b low migratory DCs (20%) displayed higher uptake frequencies compared with CD11b high migratory DCs (10%). The CD11b high migratory DC subset did not display differences between 20-nm/50-nm particles and 1,000-nm particles. In LDLNs and in resident nonmigratory CD11b high or CD11b low DC populations, particle-positive frequencies were below 5%. Morphological experiments using LSM showed that 20-nm and 50-nm nanoparticles were associated with MHC Class II-positive cells inside T cell-rich areas, where antigen presentation to naive T cells takes place. Our results are in concordance with a study that investigated the trafficking of intranasally instilled 500-nm PS beads from the respiratory tract to Figure 5 . Quantification of particle uptake by APC populations in different respiratory-tract compartments was measured by flow cytometry. PBS controls (0) or different sizes of fluorescent polystyrene particles were administrated intranasally in mice, and the single-cell suspensions obtained from trachea, BALF, lung parenchyma, and lungdraining lymph nodes (LDLNs) were analyzed 2 hours and 24 hours after particle exposure. Uptake was monitored in DC subpopulations (left and center columns) and macrophages (right column). Graphs from LDLNs show a comparison of migratory (open bars) and resident (solid bars) DC subsets. *Significant differences (P , 0.05) for particle positivity, compared with 1,000-nm particles.
x For trachea, BALF, and LP, significant differences (P , 0.05) comparing 2-hour and 24-hour time points within one APC population for one particle size.
x For LDLNs at the 24-hour time point, significant differences (P , 0.05) comparing migratory versus resident DC subsets for the positivity of one particle size. Two-tailed P values were calculated by using an unpaired t test. Bars show means 6 SEMs from at least six individual mice for each treatment across four independent experiments.
the mediastinal lymph nodes, showing that under steady-state conditions, the majority of particles was captured by AMs, but particles were also observed in a small number of DCs that had migrated to the T cell-rich areas of the mediastinal lymph nodes (28) . Recent studies identified migratory pulmonary DCs in the LDLNs as CD8a low , CD205 1 , and CD11b low/high , and reported their resemblance to airway DCs and LPDCs that are mostly CD8a low (20, 43, 44) . We previously showed that CD8a low DCs comprise the most important cell population to acquire, deliver, and present airborne OVA in LDLNs (31) . In addition, CD103 
CD11b
low DCs are localized along the airways, line vessels, and express tight-junction proteins that enable this DC subpopulation to sample particulate antigen across the epithelium (23, 26) . Additional important functions of CD103 1 CD11b low DCs include the regulation of antiviral immune responses and apoptotic cell uptake (25, 26) . Therefore, a spatial as well as a functional advantage may allow this particular DC subpopulation to acquire intraluminal particulate antigen. Indeed, in a study investigating the ability of lung DC subpopulations to sample soluble versus particulate antigens, the same CD103
1 CD11b low DC subpopulation was found to preferentially take up particulates (44) . Moreover, a study aiming to characterize migrating lung DCs has shown that particles with diameters of 0.5 to 4.5 mm coinstilled intranasally with LPS enhanced DC migration (26) . Under such conditions and in accordance with our findings, CD103 1 CD11b low DCs trafficked beads at a greater frequency and carried more beads per cell than their CD103 2 CD11b high DC counterparts (26) . Nano-sized particles may also passively drain to regional lymph nodes, as demonstrated in a recent study that investigated early (first 2 hours) translocation among differently sized and charged particles (16) . A size threshold below about 34 nm determined whether rapid transepithelial passage into the septal alveolar interstitium and subsequent passive drainage to LDLNs occurred (16) . Moreover, after footpad injection, 20-nm PS particles drained passively to popliteal LNs and localized in the subcapsular sinus 2 hours after injection, whereas 1,000-nm particles were only observed in LNs after 24 hours because of DC-dependent transport (27) . We used particles above and below the size threshold of 34 nm, and did not find evidence for the early passive drainage of significant Figure 6 . Expression of the costimulatory marker CD40 in respiratory-tract APC populations 24 hours after particle exposure, as measured by flow cytometry. Either PBS (0) or different sizes of fluorescent polystyrene particles were instilled intranasally in mice, and single-cell suspensions from trachea, BALF, lung parenchyma, and lung draining lymph nodes (LDLN) were analyzed 24 hours after exposure. CD40 expression was determined in CD11b high DCs, CD11b low DCs, and AMs. For LDLNs, the upper two rows show migratory DCs, and the lower two rows show resident DC subsets. In animals exposed to particles, APC populations positive (solid bars) and negative (open bars) for particles were analyzed for CD40 expression and compared. *Significant differences (P , 0.05) in CD40 expression, compared with PBS-instilled mice.
x Significant differences (P , 0.05) in CD40 expression, comparing particlepositive versus particle-negative cells in a single APC population. Two-tailed P values were calculated by using the unpaired t test. Bars show the means 6 SEMs from at least six individual mice for each treatment across four independent experiments. particle numbers to draining LNs 2 hours after exposure, according to both flow cytometry and LSM (data not shown). Twenty-four hours after exposure, the majority of 20-nm and 50-nm particles seen in LDLNs were associated with migratory CD11b low DCs. In the LP, however, CD11b low DCs captured 20-nm particles more frequently than 50-nm particles after 2 hours, substantiating the finding that cationic particles below a diameter of approximately 34 nm translocate cross the alveolar epithelium more readily, and may then be taken up by CD11b low DCs (16). Contrasting with particle translocation in the skin (27) , our experiments in lung tissue provided evidence that the trafficking of smaller particles to draining LNs relied on DC-dependent transportation, because we failed to detect particles located in the LDLNs earlier than 24 hours, which is the timeframe required for pulmonary DCs to shuttle particulates to regional LNs. We cannot entirely rule out that a degree of passive particle drainage to LDLNs occurred after 24 hours, and with uptake by lymph node DCs. However, at 24 hours, particles in LDLNs were mainly associated with migrating DCs, and not with resident DCs, as would have been expected with passive drainage.
We measured the expression of costimulatory surface molecules CD40 and CD86 as surrogate markers for DC activation after interactions with particles. As opsonization of particulates through the nasal route of administration may represent a relevant issue, we performed systematic PBS controls for every single experiment, assuming that any relevant bacterial contaminants present in the nasopharyngeal cavity would cause the background stimulation of AMs and DCs in the respiratory tract after PBS was administered intranasally. The frequency of CD40 and CD86 expression was generally increased in DCs containing particles, particularly with a particle size-dependent up-regulation of CD40 in CD11b high and CD11b low DCs in BALF and LP. A possible explanation for the lower frequencies of activated DCs bearing smaller particles in the airways and LP may involve an increased migration of activated DCs containing 20-nm or 50-nm particles to LDLNs, where these DCs trigger an enhanced antigen-specific CD4 1 T-cell stimulation. Because the expression of costimulatory markers in migratory DCs in LDLNs was similar for all particle sizes, increased antigen-specific CD4 1 T-cell stimulation with 20-nm particles may depend on higher numbers of 20-nm particle-bearing DCs migrating into LDLNs.
As DC subpopulations that were involved with particle trafficking represent a relatively low proportion of the total APC populations present in the respiratory tract, we investigated whether a "bystander effect" occurred in APC populations that did not capture particles. For example, when exposed to 200-nm particles, CD11b high and CD11b low DC subpopulations up-regulated CD40 without particle uptake.
Although costimulatory marker expression was also increased in AMs after particle uptake, this occurred to a lesser extent than in DCs. The activation of APCs was unlikely attributable to the endotoxin contamination of the particles, because LPS testing was systematically performed for all particle batches, and the amount of particles instilled was within the range used for other studies that failed to detect excess inflammation (27, 28, 45) . In contrast with our study, a long-term (40 days after instillation) inhibitory effect for the induction of allergic airway inflammation (AAI) in a mouse model 40 days after the intratracheal delivery of 50-nm PS particles has recently been observed (45) . DC migration to LDLNs was significantly reduced in particle-treated animals during the induction of AAI, leading to an attenuated antigenspecific CD4
1 T-cell and Th2-biased immune response (45) . However, this study did not address the localization of particles within the lung compartments or APCs. More congruent with our study, a preferential uptake of 40-nm particles to 1,000-nm particles by intradermal DCs, followed by the activation and migration of DCs to the draining LNs, was recently described (46) . Due to a degree of biological variation between animals, our data did not show significant differences in CD4
1 T-cell proliferation between 20-nm and 1,000-nm particles. However, in animals exposed to 20-nm but not 1,000-nm particles, significant antigenspecific CD4
1 T-cell proliferation occurred, compared with the control group that received antigen only.
In conclusion, to our knowledge, we have provided the initial evidence of size-dependent uptake and trafficking patterns of nanoparticles by respiratory-tract DCs and AMs from different anatomical compartments to LDLNs. As a functional consequence, enhanced antigen-specific CD4
1 T-cell proliferation occurred in animals exposed to 20-nm particles. Therefore, particulate size is a key parameter determining the uptake and trafficking by respiratory-tract APC populations, as well as downstream immune responses in LDLNs. These findings have important implications for the development of novel diagnostic and therapeutic carriers for the pulmonary route of administration.
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